Literature DB >> 9379036

Cloning and characterization of the human recombination activating gene 1 (RAG1) and RAG2 promoter regions.

A A Zarrin1, I Fong, L Malkin, P A Marsden, N L Berinstein.   

Abstract

Recombination activating gene 1 (RAG1) and RAG2 are the essential and tissue-specific components of V(D)J recombination. We have characterized the genomic organization of the human RAG locus, mapped the transcriptional initiation sites, and partially sequenced and performed functional reporter assays on the 5' flanking regions of human RAG1 and RAG2. Transcription initiation sites were mapped by rapid amplification of 5' cDNA ends, primer extension, and/or RNase protection in normal thymocytes, three pre-B cell lines, and a mature B cell line. A single promoter region was used for RAG1 transcription. In contrast, transcription of RAG2 initiates at two distinct regions of the genome. The 5'-flanking region of the human RAG2 gene is TATA-less; however, there is a GATAA consensus at position -34 with respect to the major transcriptional initiation site of RAG1. Promoter regions of human RAG1 and RAG2 are active in both lymphoid and nonlymphoid cell lines, suggesting that an outside regulatory element is probably involved in the tissue-specific transcriptional regulation of the RAG genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379036

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  RAG2 is regulated differentially in B and T cells by elements 5' of the promoter.

Authors:  R J Monroe; F Chen; R Ferrini; L Davidson; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.

Authors:  Q F Wang; J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes.

Authors:  Laurent Verkoczy; Djemel Aït-Azzouzene; Patrick Skog; Annica Märtensson; Julie Lang; Bao Duong; David Nemazee
Journal:  Immunity       Date:  2005-04       Impact factor: 31.745

4.  Association of clinical status of follicular lymphoma patients after autologous stem cell transplant and quantitative assessment of lymphoma in blood and bone marrow as measured by SYBR Green I polymerase chain reaction.

Authors:  Nancy Pennell; Anthony Woods; Marciano Reis; Rena Buckstein; David Spaner; Kevin Imrie; Karen Hewitt; Angela Boudreau; Arun Seth; Neil L Berinstein
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

5.  High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2).

Authors:  Sabrina Battista; Monica Fedele; Josefina Martinez Hoyos; Francesca Pentimalli; Giovanna Maria Pierantoni; Rosa Visone; Ivana De Martino; Carlo Maria Croce; Alfredo Fusco
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

6.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  Correction of murine Rag2 severe combined immunodeficiency by lentiviral gene therapy using a codon-optimized RAG2 therapeutic transgene.

Authors:  Niek P van Til; Helen de Boer; Nomusa Mashamba; Agnieszka Wabik; Marshall Huston; Trudi P Visser; Elena Fontana; Pietro Luigi Poliani; Barbara Cassani; Fang Zhang; Adrian J Thrasher; Anna Villa; Gerard Wagemaker
Journal:  Mol Ther       Date:  2012-06-12       Impact factor: 11.454

8.  Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision.

Authors:  Anne Doster; Saskia Ziegler; Sandra Foermer; Ralf Joachim Rieker; Klaus Heeg; Isabelle Bekeredjian-Ding
Journal:  Immunology       Date:  2013-06       Impact factor: 7.397

9.  Transcript expression of two Iglambda rearrangements and RAG-1/RAG-2 in a mature human B cell producing IgMlambda islet cell autoantibody.

Authors:  Carmen Benito; Ramon Gomis; Josefa Fernández-Alvarez; Elena F Usac; Teresa Gallart
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

Review 10.  Omenn syndrome: a disorder of Rag1 and Rag2 genes.

Authors:  A Villa; S Santagata; F Bozzi; L Imberti; L D Notarangelo
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.